Endocrine research
CJC-1295 vs Sermorelin
Long-acting GHRH analogue language beside sermorelin reference framing.
Overview
This comparison separates CJC-1295 and Sermorelin for laboratory reference—not product selection.
CJC-1295: Synthetic growth hormone releasing hormone analog with short half-life enabling pulsatile GH secretion patterns resembling natural physiology. Unlike CJC-1295 with DAC, this versio…
Sermorelin: Sermorelin is a synthetic 29-amino acid analog of human growth hormone-releasing hormone that stimulates natural growth hormone production while preserving physiological pulsatile…
Key differences
- CJC-1295 is commonly filed under Tissue repair & recovery; Sermorelin under GLP-1 & metabolic.
- The useful distinction is research question and receptor context—not relative potency or practical ranking.
Mechanistic differences
CJC-1295: Synthetic growth hormone releasing hormone analog with short half-life enabling pulsatile GH secretion patterns resembling natural physiology. Unlike CJC-1295 w…
Sermorelin: Sermorelin is a synthetic 29-amino acid analog of human growth hormone-releasing hormone that stimulates natural growth hormone production while preserving phys…
Pharmacology
CJC-1295: Synthetic growth hormone releasing hormone analog with short half-life enabling pulsatile GH secretion patterns resembling natural physiology. Unlike CJC-1295 w…
Sermorelin: Subcutaneous injection provides optimal bioavailability for binding GHRH receptors, stimulating pulsatile GH release while maintaining hypothalamic-pituitary ax…
Research focus
CJC-1295: Tissue repair & recovery: Synthetic growth hormone releasing hormone analog with short half-life enabling pulsatile GH secretion patterns resembling natural physiology. U…
Sermorelin: GLP-1 & metabolic: Sermorelin is a synthetic 29-amino acid analog of human growth hormone-releasing hormone that stimulates natural growth hormone production while preser…
At a glance
Practical differentiation
- AXIOM does not provide dosing, administration, or protocol guidance.
- Catalogue links appear only where AXIOM lists a research-use product.
- Reference-only compounds remain comparison terms without implying availability.
References
- pubmed.ncbi.nlm.nih.gov/16352683/
- pubmed.ncbi.nlm.nih.gov/17018654/
- pubmed.ncbi.nlm.nih.gov/15817669/
- pubmed.ncbi.nlm.nih.gov/16822960/
- pubmed.ncbi.nlm.nih.gov/19386527/
- pubmed.ncbi.nlm.nih.gov/2877535/
- pubmed.ncbi.nlm.nih.gov/8772599/
- pubmed.ncbi.nlm.nih.gov/9141536/
FAQ
Does this page recommend CJC-1295 or Sermorelin?
No. It is an editorial comparison for research context only.
Does AXIOM provide protocol guidance?
No. Protocol and dosing decisions belong with qualified laboratory teams and source literature.